Huixian Ye
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Huixian Ye has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
Bin Xiao
Key Laboratory of Jiangxi Province for Special Optoelectronic Artificial Crystal Materials, Institute of Applied Chemistry, School of Chemistry and Chemical Engineering, Jinggangshan University, Ji'an, Jiangxi 343009, PR China
4 shared publications- Hailing Li
Hubei Key Laboratory of Bioinorganic Chemistry & Materia Medica, School of Chemistry and Chemical Engineering, Huazhong University of Science & Technology, Wuhan 430074, PR China
4 shared publications Yan Sui
School of Chemistry and Chemical Engineering, Key Laboratory of Jiangxi Province for Special Optoelectronic Artificial Crystal Materials, Jinggangshan University, Ji'an, Jiangxi 343009, PR China
3 shared publications- Zhonghong Gao
Hubei Key Laboratory of Bioinorganic Chemistry & Materia Medica, School of Chemistry and Chemical Engineering, Huazhong University of Science & Technology, Wuhan, 430074, PR China
3 shared publications Hongmei Chen
Key Laboratory of Jiangxi Province for Special Optoelectronic Artificial Crystal Materials, Institute of Applied Chemistry, School of Chemistry and Chemical Engineering, Jinggangshan University, Ji'an, Jiangxi 343009, PR China
2 shared publicationsJinming Wu
Department of Experimental Medical Science, Faculty of Medicine, Lund University, 22100, Lund, Sweden
2 shared publications
Latest Publications
- 6 June 2026
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 283, 113378
Hydrophilicity of heme derivatives influences site-specific tyrosine nitration in MnSOD
- 6 June 2026
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 283, 113378
Hydrophilicity of heme derivatives influences site-specific tyrosine nitration in MnSOD
- 28 March 2026
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 280, 113319
Insight into the interaction of heme with human calcitonin (hCT) and its inhibitory effect on hCT aggregation
- 28 March 2026
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 280, 113319
Insight into the interaction of heme with human calcitonin (hCT) and its inhibitory effect on hCT aggregation
- 3 February 2026
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry A
- Vol. 14 (19) , 11722-11734
In situ interfacial assembly of P-MXene@COF hybrids for flame-retardant and smoke-suppressive epoxy resin
In situ interfacial assembly of P-MXene@COF enhances the flame retardancy and smoke suppression of epoxy resin via gas-phase radical quenching and condensed-phase shielding, while maintaining mechanical properties.
- 3 February 2026
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry A
- Vol. 14 (19) , 11722-11734
In situ interfacial assembly of P-MXene@COF hybrids for flame-retardant and smoke-suppressive epoxy resin
In situ interfacial assembly of P-MXene@COF enhances the flame retardancy and smoke suppression of epoxy resin via gas-phase radical quenching and condensed-phase shielding, while maintaining mechanical properties.
- 20 September 2024
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 53 (41) , 17036-17049
Peroxynitrite scavenger FeTPPS binds with hCT to effectively inhibit its amyloid aggregation
Human calcitonin (hCT) is an endogenous polypeptide commonly employed in treating bone resorption-related illnesses, but its clinical application is limited due to its high aggregation tendency. Metalloporphyrins are effective in suppressing amyloid fibrillation, positioning them as potential drug candidates for amyloidogenic disorders like Alzheimer's and type 2 diabetes. In this work, we investigated the effects of Fe(III) meso-tetra(4-sulfonatophenyl)porphine chloride (FeTPPS), a highly efficient ONOO− decomposition catalyst, on hCT aggregation. Our findings reveal that FeTPPS effectively precludes hCT fibrillation by stabilizing the monomers and delaying the structural transition from α-helix bundles to β-sheet-rich aggregates. The macrocyclic ring of FeTPPS plays a significant role in disrupting hCT self-associations. Among various porphyrin analogs, those with an iron center and negatively charged peripheral substituents exhibit a stronger inhibitory effect on hCT aggregation. Spectroscopic analyses and computational simulations indicate that FeTPPS binds to hCT's core aggregation region via complexation with His20 in a 1 : 1 molar ratio. Hydrophobic interaction, hydrogen bonding, and π–π stacking with the residues involving Tyr12, Phe19, and Ala26 also contribute to the interactions. Collectively, our study provides a promising approach for developing novel hCT drug formulations and offers theoretical guidance for designing metalloporphyrin-based inhibitors for various amyloidosis conditions.
- 20 September 2024
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 53 (41) , 17036-17049
Peroxynitrite scavenger FeTPPS binds with hCT to effectively inhibit its amyloid aggregation
Human calcitonin (hCT) is an endogenous polypeptide commonly employed in treating bone resorption-related illnesses, but its clinical application is limited due to its high aggregation tendency. Metalloporphyrins are effective in suppressing amyloid fibrillation, positioning them as potential drug candidates for amyloidogenic disorders like Alzheimer's and type 2 diabetes. In this work, we investigated the effects of Fe(III) meso-tetra(4-sulfonatophenyl)porphine chloride (FeTPPS), a highly efficient ONOO− decomposition catalyst, on hCT aggregation. Our findings reveal that FeTPPS effectively precludes hCT fibrillation by stabilizing the monomers and delaying the structural transition from α-helix bundles to β-sheet-rich aggregates. The macrocyclic ring of FeTPPS plays a significant role in disrupting hCT self-associations. Among various porphyrin analogs, those with an iron center and negatively charged peripheral substituents exhibit a stronger inhibitory effect on hCT aggregation. Spectroscopic analyses and computational simulations indicate that FeTPPS binds to hCT's core aggregation region via complexation with His20 in a 1 : 1 molar ratio. Hydrophobic interaction, hydrogen bonding, and π–π stacking with the residues involving Tyr12, Phe19, and Ala26 also contribute to the interactions. Collectively, our study provides a promising approach for developing novel hCT drug formulations and offers theoretical guidance for designing metalloporphyrin-based inhibitors for various amyloidosis conditions.
- 12 February 2022
- Published by Royal Society of Chemistry (RSC) in Inorganic Chemistry Frontiers
- Vol. 9 (7) , 1520-1532
Structure and mechanism behind the inhibitory effect of water soluble metalloporphyrins on Aβ1–42aggregation
Although the exact molecular mechanism of the pathogenesis of Alzheimer's disease (AD) is still unclear, compounds that can inhibit the aggregation of amyloid-β peptide (Aβ1–42) or scavenge the highly toxic peroxynitrite (ONOO−) free radical have been confirmed to delay or alleviate AD to a certain extent. Thus, the design and screening of dual-function compounds are important for biomedical aims. A group of water soluble metallopophyrins, including FeTMPyP, MnTMPyP, FeTBAP and MnTBAP, are well known active ONOO− decomposition catalysts, which share the structural similarity of planar aromatic conjugation with a valuable class of inhibitors against amyloid fibrillation, although their effects on Aβ1–42 aggregation and toxicity have been less explored. Here, we aimed to investigate their inhibitory effects on Aβ1–42 aggregation, in particular, how this relates to the structure. Fluorescence and TEM results showed that cationic metalloporphyrins (FeTMPyP and MnTMPyP) exhibited a stronger inhibitory effect on Aβ1–42 fibrillation than anionic metalloporphyrins (FeTBAP and MnTBAP), and the metalloporphyrin with an iron center is more effective than the one with a manganese center. Cell experiments revealed that the protective effect of these metalloporphyrins on Aβ1–42-induced cytotoxicity is consistent with their anti-fibrillization activity. We also provide evidence that metalloporphyrins stabilize the Aβ1–42 monomer, resulting in interfering with its self-assembly. The electrostatic interaction between the tetraphenylporphyrin of a metalloporphyrin and an amyloid peptide determines the inhibitory effect of metalloporphyrins. However, for the same ligand porphyrin, Fe-porphyrin is more effective than Mn-porphyrin, which can be attributed to the additional coordination bond between the central metal atom (Fe) and the amyloid peptide. The conclusions were further confirmed by the use of another amyloid polypeptide (hIAPP) and other anionic metalloporphyrins (FeTPPS and MnTPPS). We believe that the findings will aid in the development of metalloporphyrin agents targeting AD and other amyloid diseases.
- 12 February 2022
- Published by Royal Society of Chemistry (RSC) in Inorganic Chemistry Frontiers
- Vol. 9 (7) , 1520-1532
Structure and mechanism behind the inhibitory effect of water soluble metalloporphyrins on Aβ1–42aggregation
Although the exact molecular mechanism of the pathogenesis of Alzheimer's disease (AD) is still unclear, compounds that can inhibit the aggregation of amyloid-β peptide (Aβ1–42) or scavenge the highly toxic peroxynitrite (ONOO−) free radical have been confirmed to delay or alleviate AD to a certain extent. Thus, the design and screening of dual-function compounds are important for biomedical aims. A group of water soluble metallopophyrins, including FeTMPyP, MnTMPyP, FeTBAP and MnTBAP, are well known active ONOO− decomposition catalysts, which share the structural similarity of planar aromatic conjugation with a valuable class of inhibitors against amyloid fibrillation, although their effects on Aβ1–42 aggregation and toxicity have been less explored. Here, we aimed to investigate their inhibitory effects on Aβ1–42 aggregation, in particular, how this relates to the structure. Fluorescence and TEM results showed that cationic metalloporphyrins (FeTMPyP and MnTMPyP) exhibited a stronger inhibitory effect on Aβ1–42 fibrillation than anionic metalloporphyrins (FeTBAP and MnTBAP), and the metalloporphyrin with an iron center is more effective than the one with a manganese center. Cell experiments revealed that the protective effect of these metalloporphyrins on Aβ1–42-induced cytotoxicity is consistent with their anti-fibrillization activity. We also provide evidence that metalloporphyrins stabilize the Aβ1–42 monomer, resulting in interfering with its self-assembly. The electrostatic interaction between the tetraphenylporphyrin of a metalloporphyrin and an amyloid peptide determines the inhibitory effect of metalloporphyrins. However, for the same ligand porphyrin, Fe-porphyrin is more effective than Mn-porphyrin, which can be attributed to the additional coordination bond between the central metal atom (Fe) and the amyloid peptide. The conclusions were further confirmed by the use of another amyloid polypeptide (hIAPP) and other anionic metalloporphyrins (FeTPPS and MnTPPS). We believe that the findings will aid in the development of metalloporphyrin agents targeting AD and other amyloid diseases.
- 10 July 2017
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 46 (31) , 10315-10323
NPY binds with heme to form a NPY–heme complex: enhancing peroxidase activity in free heme and promoting NPY nitration and inactivation
Neuropeptide Y (NPY) is a member of the pancreatic peptide family of neuropeptides that play a crucial role in numerous central and peripheral nervous system responses. Recently, it has been shown that NPY protects cells against neurotoxic damage from β-amyloid peptides (Aβ) in Alzheimer's disease (AD). Heme is a common factor linking several metabolic perturbations in AD and altered heme metabolism has been shown to be related to the pathologies of AD. Thus, heme may have a chance to act on NPY and potentially counteract its function. To explore this, UV-visible spectroscopy, fluorescence spectroscopy and differential pulse voltammetry (DPV) were used to demonstrate that NPY can bind with heme to form a NPY–heme complex and the binding enhances the peroxidase activity of heme. Dot blotting results indicate that NPY is easily nitrated upon binding with heme when H2O2 and NO2 − are present. Furthermore, LC-MS/MS results confirm that tyrosine36 (Tyr36), an important amino acid residue of NPY in binding and activating neuropeptide receptors, can be nitrated during the nitration process. Thereafter, we used mutant peptide NPY(3N) (Tyr36 replaced by 3-nitrotyrosine) to investigate the impact of nitration on the structure and bioactivity of the peptide. Our results show that Tyr36 nitration destabilizes the α-helix conformation of the peptide, and counteracts NPY-induced inhibition of cAMP accumulation in SK-N-MC cells. Collectively, these data imply that the self-association of NPY with heme potentially induces tyrosine nitration, destroys the active monomeric conformation of the peptide and thereby counteracts its bioactivity.
- 10 July 2017
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 46 (31) , 10315-10323
NPY binds with heme to form a NPY–heme complex: enhancing peroxidase activity in free heme and promoting NPY nitration and inactivation
Neuropeptide Y (NPY) is a member of the pancreatic peptide family of neuropeptides that play a crucial role in numerous central and peripheral nervous system responses. Recently, it has been shown that NPY protects cells against neurotoxic damage from β-amyloid peptides (Aβ) in Alzheimer's disease (AD). Heme is a common factor linking several metabolic perturbations in AD and altered heme metabolism has been shown to be related to the pathologies of AD. Thus, heme may have a chance to act on NPY and potentially counteract its function. To explore this, UV-visible spectroscopy, fluorescence spectroscopy and differential pulse voltammetry (DPV) were used to demonstrate that NPY can bind with heme to form a NPY–heme complex and the binding enhances the peroxidase activity of heme. Dot blotting results indicate that NPY is easily nitrated upon binding with heme when H2O2 and NO2 − are present. Furthermore, LC-MS/MS results confirm that tyrosine36 (Tyr36), an important amino acid residue of NPY in binding and activating neuropeptide receptors, can be nitrated during the nitration process. Thereafter, we used mutant peptide NPY(3N) (Tyr36 replaced by 3-nitrotyrosine) to investigate the impact of nitration on the structure and bioactivity of the peptide. Our results show that Tyr36 nitration destabilizes the α-helix conformation of the peptide, and counteracts NPY-induced inhibition of cAMP accumulation in SK-N-MC cells. Collectively, these data imply that the self-association of NPY with heme potentially induces tyrosine nitration, destroys the active monomeric conformation of the peptide and thereby counteracts its bioactivity.